Ainos (AIMD)
NASDAQ:AIMD
US Market

Ainos (AIMD) Stock Price & Analysis

44 Followers

AIMD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.65 - $5.10
Previous Close$0.68
Volume86.40K
Average Volume (3M)738.33K
Market Cap
$5.19M
Enterprise Value$9.84M
Total Cash (Recent Filing)$1.03M
Total Debt (Recent Filing)$5.68M
Price to Earnings (P/E)
Beta0.60
Aug 12, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.16
Shares Outstanding6,284,300
10 Day Avg. Volume3,335,507
30 Day Avg. Volume738,330
Standard Deviation0.35
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.36
Price to Sales (P/S)42.73
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue105.03
Enterprise Value/Gross Profit-38.78
Enterprise Value/Ebitda-2.04
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

AIMD FAQ

What was Ainos’s price range in the past 12 months?
Ainos lowest stock price was $0.65 and its highest was $5.10 in the past 12 months.
    What is Ainos’s market cap?
    Currently, no data Available
    When is Ainos’s upcoming earnings report date?
    Ainos’s upcoming earnings report date is Aug 12, 2024 which is in 15 days.
      How were Ainos’s earnings last quarter?
      Ainos released its earnings results on May 13, 2024. The company reported -$0.574 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.574.
        Is Ainos overvalued?
        According to Wall Street analysts Ainos’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Ainos pay dividends?
          Ainos does not currently pay dividends.
          What is Ainos’s EPS estimate?
          Ainos’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Ainos have?
          Ainos has 7,663,022 shares outstanding.
            What happened to Ainos’s price movement after its last earnings report?
            Ainos reported an EPS of -$0.574 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.887%.
              Which hedge fund is a major shareholder of Ainos?
              Currently, no hedge funds are holding shares in AIMD
              ---

              Ainos Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -86.46%
              12-Months-Change

              Fundamentals

              Return on Equity
              -52.95%
              Trailing 12-Months
              Asset Growth
              -18.94%
              Trailing 12-Months

              Company Description

              Ainos

              Amarillo Biosciences, Inc. engages in developing biologics for the treatment of human and animal diseases. It focuses on research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha that is administered in a proprietary low dose oral form. The company was founded by Joseph M. Cummins in June 1984 and is headquartered in Amarillo, TX.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Varex Imaging
              Merit Medical Systems
              Tandem Diabetes Care
              Cutera
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis